Investing.com - Enanta reported on Monday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Enanta announced earnings per share of $-1.27 on revenue of $20.32M. Analysts polled by Investing.com anticipated EPS of $-1.25 on revenue of $22.87M.
Enanta shares are down 37% from the beginning of the year and are trading at $46.40 , down-from-52-week-high.
Enanta follows other major Healthcare sector earnings this month
Enanta's report follows an earnings beat by Eli Lilly on November 1, who reported EPS of $1.98 on revenue of $6.94B, compared to forecasts EPS of $1.91 on revenue of $6.91B.
AbbVie had beat expectations on October 28 with third quarter EPS of $3.66 on revenue of $14.81B, compared to forecast for EPS of $3.58 on revenue of $14.93B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar